Medpace Holdings (MEDP) Receivables - Net (2015 - 2026)

Medpace Holdings has reported Receivables - Net for 12 years, with the latest figure at $394.6 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Net rose 32.31% year-over-year to $394.6 million; the trailing twelve-month figure through Mar 2026 stood at $394.6 million (up 32.31% YoY), and the FY2025 full-year result was $402.1 million, up 35.63% from the prior year.
• Receivables - Net for Q1 2026 stood at $394.6 million, down from $402.1 million in the prior quarter.
• The five-year high for Receivables - Net was $402.1 million in Q4 2025, with the low at $182.1 million in Q2 2022.
• Historically, Receivables - Net has averaged $298.1 million across 5 years, with a median of $296.4 million in 2024.
• Annual changes were most pronounced in 2022 — Receivables - Net surged 71.43% — and 2024, when it dropped 0.66%.
• Medpace Holdings' Receivables - Net stood at $253.4 million in 2022, then rose by 17.76% to $298.4 million in 2023, then retreated by 0.66% to $296.4 million in 2024, then surged by 35.63% to $402.1 million in 2025, then retreated by 1.86% to $394.6 million in 2026.
• The last three Receivables - Net figures came in at $394.6 million (Q1 2026), $402.1 million (Q4 2025), and $373.0 million (Q3 2025), per Business Quant data.